Mirati Therapeutics, Inc. Share | Buy US Stock from India on Kuvera

Q: Can I buy Mirati Therapeutics, Inc. shares in India?

<div>Kuvera makes it super convenient to trade in US Stocks from India. You can buy / sell Mirati Therapeutics, Inc. stocks after a simple registration process. </div>

Q: How to buy Mirati Therapeutics, Inc. shares in India?

<div> To buy Mirati Therapeutics, Inc. shares from India, just follow these simple steps: <div>Step 1: Login to the Kuvera app or website and go to US Stocks.</div> <div>Step 2: Link your existing Vested US investing account, or create a new one.</div> <div>Step 3: Complete all the KYC process and fund your US Stock trading account.</div> <div>Step 4: Place buy order for Mirati Therapeutics, Inc. and you are done!</div> </div>

Q: What is the share price of Mirati Therapeutics, Inc.?

<div>The share price of Mirati Therapeutics, Inc. is USD 58.7 as on 17 Dec.</div>

Q: What is the Market Capitalization of Mirati Therapeutics, Inc.?

<div>Market capitalization or market cap in short, is the total value of all the stocks of a particular company. Market capitalization of Mirati Therapeutics, Inc. is USD 0 as on 17 Dec.</div>

Q: What is the PE ratio of Mirati Therapeutics, Inc.?

<div> The price-to-earnings ratio (P/E ratio) in case of stocks of a company is the ratio between its current share price relative to its earnings per share (EPS). A high P/E ratio indicates that the stock is overvalued in relation to the earnings (revenue) generated. PE ratio of Mirati Therapeutics, Inc. is N/A as on 17 Dec. </div>

Q: Is Mirati Therapeutics, Inc. a good stock to buy?

<div>Kuvera provides relevant fundamental details of Mirati Therapeutics, Inc. to help you evaluate. We also recommend you do thorough research before making an investment decision.</div>

Q: In which sector / industry does Mirati Therapeutics, Inc. operate?

<div> Mirati Therapeutics, Inc. operates in Healthcare / Biotechnology

Healthcare Biotechnology

$58.7

(9:00 pm IST)

Loading Chart

Previous close

$58.70

Open

$58.70

1.56%

-12.18%

Market cap

Insights

MRTX price is above its 200 day moving average

MRTX is in the highest 10% returns in the past year. It is a high momentum stock. High momentum stocks tend to outperform in the near term.

In beta. Send feedback here.

Compare with other stock

About Mirati Therapeutics, Inc.

Mirati Therapeutics, Inc. is a commercial-stage oncology company. The Company is developing novel therapeutics to address the genetic and immunological promoters of cancer. The Company's product KRAZATI is an oral targeted treatment option for adult patients with KRAS G12C-mutated locally advanced or metastatic non-small cell lung cancer (NSCLC).

Its MRTX1133 is an investigational, selective, and potent KRAS G12D inhibitor. Its MRTX1719 is an investigational synthetic lethal PRMT5 inhibitor designed to specifically target the PRMT5/ methylthioadensoine (MTA) complex. Its MRTX0902 is a potent, selective SOS1 inhibitor, designed to improve anti-tumor efficacy in combination with targeted mitogen-activated protein kinase (MAPK)-pathway inhibitors. Its Sitravatinib is an investigational spectrum-selective kinase inhibitor designed to potently inhibit receptor tyrosine kinases (RTKs) and enhance immune responses through the inhibition of immunosuppressive signaling. .

FAQs

Can I buy Mirati Therapeutics, Inc. shares in India?

How to buy Mirati Therapeutics, Inc. shares in India?

What is the share price of Mirati Therapeutics, Inc.?

What is the Market Capitalization of Mirati Therapeutics, Inc.?

What is the PE ratio of Mirati Therapeutics, Inc.?

Is Mirati Therapeutics, Inc. a good stock to buy?

In which sector / industry does Mirati Therapeutics, Inc. operate?